Global Artificial Heart-Lung Machines Market Analysis Report
Executive Summary
The global Artificial Heart-Lung Machines (AHLM) market, a critical segment within cardiovascular perfusion and cardiac surgery, is characterized by technologically advanced, life-sustaining systems that temporarily assume the functions of the heart and lungs during open-heart procedures. Valued at an estimated $XX million USD in 2025, the market is projected to reach $XX million USD by 2036, advancing at a steady Compound Annual Growth Rate (CAGR) of X.X% from 2026 to 2036. This growth is underpinned by the rising global burden of cardiovascular diseases (CVDs), increasing volumes of complex cardiac surgeries, expanding indications into areas like lung transplants and ECMO support, and ongoing technological refinements enhancing patient safety and clinical outcomes.
Segments Analysis
-
By Product Type & Configuration:
-
Integrated Console-Based Systems: The conventional, dominant segment featuring a single console integrating the blood pump, oxygenator, heat exchanger, venous reservoir, and sophisticated monitoring/safety systems. Engineered for the highest level of control and safety in major cardiac centers.
-
Modular & Mobile Systems: Flexible configurations that allow for greater customization and adaptability. Often used in hybrid operating rooms, trauma centers, or for specialized procedures like minimally invasive cardiac surgery (MICS) and thoracic aortic repairs.
-
Disposables & Consumables (High-Volume Segment): Includes oxygenators, centrifugal pumps, tubing packs, cannulae, and filters. This is a high-growth, recurring revenue segment driven by procedure volumes and stringent single-use protocols to prevent infection.
-
-
By Pump Technology:
-
Centrifugal Pumps: The modern standard, generating flow through constrained vortex or impeller designs. They are associated with reduced hemolysis, lower risk of air embolism, and afterload sensitivity, enhancing patient safety.
-
Roller Pumps: Traditional positive displacement pumps still in use in some settings for specific applications like pediatric surgery or cardioplegia delivery, but largely superseded by centrifugal technology for main arterial support.
-
-
By Application:
-
Cardiac Surgery: The primary application, including Coronary Artery Bypass Grafting (CABG), Valve Repair/Replacement, and Congenital Heart Defect Corrections.
-
Extracorporeal Membrane Oxygenation (ECMO): A rapidly growing application where portable heart-lung machines provide temporary cardiac and/or respiratory support for critically ill patients (e.g., severe ARDS, post-cardiotomy shock, bridge to transplant).
-
Other: Includes use in lung transplant surgeries and major thoracic aortic procedures.
-
Regional Analysis
-
North America: The largest market, driven by high procedure volumes, advanced healthcare infrastructure, favorable reimbursement frameworks, and early adoption of next-generation perfusion technologies and minimally invasive surgical techniques.
-
Europe: A mature market with high standards for patient safety and quality. Growth is supported by an aging population, high incidence of CVD, and strong clinical research in perfusion science and ECMO.
-
Asia-Pacific: The fastest-growing regional market. Explosive growth is fueled by rising healthcare expenditures, expanding access to cardiac care, increasing medical tourism, growing surgical volumes in China, India, Japan, and South Korea, and significant investments in hospital infrastructure.
-
Latin America, Middle East & Africa: Emerging markets with gradual growth potential. Growth is concentrated in major urban medical centers and is driven by government initiatives to modernize cardiac care and the training of specialized cardiac surgical teams.
Competitive Landscape & Key Players
The market is consolidated, dominated by a few global medical technology giants with extensive portfolios in cardiac surgery.
-
Global Market Leaders: Getinge AB (Maquet), LivaNova PLC, Medtronic plc, Terumo Cardiovascular Systems Corporation.
-
Specialized & Niche Players: Xenios AG (Fresenius Medical Care) (focused on ECMO and advanced life support), Eurosets S.r.l., Chalice Medical Ltd., Nipro Medical Corporation.
-
Disposables & Consumables Manufacturers: In addition to the above, companies like Microport Scientific Corporation, Braile Biomédica, and several regional manufacturers compete in the high-volume consumables segment.
Porter’s Five Forces Analysis
-
Threat of New Entrants: Very Low. The market presents exceptionally high barriers: stringent regulatory approval (FDA, CE Mark) for life-critical Class III medical devices; massive R&D and clinical trial costs; complex manufacturing requiring clean-room conditions; and entrenched customer relationships and high brand loyalty in a risk-averse field.
-
Bargaining Power of Suppliers: Moderate. For specialized components like bi-compatible coating materials, high-precision pressure/flow sensors, and proprietary gas exchange membranes, suppliers hold technical leverage. However, large OEMs often have long-term contracts or in-house capabilities to mitigate this.
-
Bargaining Power of Buyers (Hospitals): High. Buyers are sophisticated hospital procurement groups and cardiac centers. They negotiate aggressively on capital equipment pricing and consumables contracts due to high procedure volumes. However, switching costs (training, compatibility) for core systems are high.
-
Threat of Substitutes: Low. There is no true technological substitute for mechanical cardiopulmonary bypass during open-heart surgery. The threat is procedural: the growth of off-pump CABG (OPCAB) and minimally invasive procedures that avoid the use of full bypass. However, many complex procedures still require the machine.
-
Competitive Rivalry: High. Competition among the few major players is intense, based on technological innovation (miniaturization, biocompatibility, data integration), clinical evidence, comprehensive service networks, and pricing strategies for both capital equipment and high-margin disposable kits.
SWOT Analysis
-
Strengths: Critical, life-saving technology with no alternative for major procedures; continuous innovation improving biocompatibility and safety; strong brand loyalty and high switching costs; recurring revenue from high-margin disposables.
-
Weaknesses: Extremely high product liability and regulatory burden; market maturity and slow growth in developed regions; vulnerability to procedural shifts towards off-pump and transcatheter techniques.
-
Opportunities: Explosive growth of ECMO applications for critical care; expansion into high-growth emerging markets (APAC); integration of AI and advanced hemodynamic monitoring for personalized perfusion; development of compact systems for hybrid ORs and emergency use.
-
Threats: Intense pricing pressure from hospital procurement groups; risks associated with product recalls; competition from refurbished equipment markets; lengthy and costly product development cycles.
Trend Analysis
-
Miniaturization & Portability: Driven by ECMO and MICS trends, leading to the development of more compact, integrated, and easily transportable systems for use both inside and outside the OR.
-
Enhanced Biocompatibility & Coatings: Continuous improvement in heparin-bonded and phosphorylcholine-coated circuits to reduce systemic inflammatory response, platelet activation, and blood transfusion requirements.
-
Digital Integration & Data Analytics: Incorporation of advanced sensors and connectivity for real-time monitoring, data logging, and integration with hospital EMRs. AI for predictive analytics on perfusion parameters and patient outcomes is an emerging frontier.
-
Expansion of Indications: Growing utilization in non-cardiac surgeries requiring thoracic access, complex trauma resuscitation, and as a vital tool in lung transplantation.
Drivers & Challenges
-
Drivers: Rising global prevalence of cardiovascular diseases; increasing number of complex and re-do cardiac surgeries; growing adoption of ECMO for cardiac and respiratory failure; technological advancements improving safety and outcomes; expanding training of cardiac surgeons and perfusionists worldwide.
-
Challenges: High cost of systems and disposables limiting access in low-resource settings; steep learning curve and requirement for highly specialized perfusionist teams; procedural shift towards transcatheter aortic valve replacement (TAVR) and other less-invasive interventions reducing some bypass volumes; stringent and evolving regulatory landscapes.
Value Chain Analysis
-
R&D & Design: Intensive research in hemodynamics, biomaterials, and systems engineering to develop safer, more efficient pumps, oxygenators, and circuits.
-
Precision Manufacturing: High-stakes manufacturing under stringent quality management systems (ISO 13485) and clean-room conditions for both durable hardware and sterile, single-use disposables.
-
Regulatory Affairs & Clinical Validation: Navigating complex global regulatory pathways (FDA PMA/510(k), CE Mark) requiring extensive clinical data to demonstrate safety and efficacy.
-
Specialized Distribution & Training: Sales through specialized medical device distributors and direct OEM teams. Comprehensive, mandatory training programs for clinical perfusionists are a critical part of the sales process.
-
Clinical Application & Support: Use in hospital cardiac ORs and ICUs. Generates ongoing revenue through service contracts, software updates, and the continuous sale of procedure-specific disposable kits.
Quick Recommendations for Stakeholders
-
For Manufacturers: Focus R&D on miniaturized systems for ECMO/MICS and integrated digital/AI platforms for data-driven perfusion. Develop cost-optimized, reliable systems for high-growth emerging markets without compromising core safety features. Strengthen service and educational offerings to build loyalty with perfusionist teams.
-
For Healthcare Providers (Hospitals): Prioritize total cost of ownership (including disposables and service) over initial capital cost. Invest in continuous training for perfusionists on the latest technologies and protocols. Consider the strategic role of ECMO capabilities and invest in systems that support both OR and ICU applications.
-
For Investors: Focus on companies with leading market share in high-margin disposable consumables and strong positions in the high-growth ECMO segment. Monitor firms with innovative digital health integrations for perfusion data management. Evaluate companies with successful strategies for penetrating the Asia-Pacific market.
-
For Regulatory Bodies & Associations: Support the development of international standards for perfusion safety and training. Facilitate pathways for innovative technologies that improve patient outcomes. Promote registries and data collection to benchmark performance and guide best practices in extracorporeal circulation.
Table of Contents
Global Artificial Heart Lung Machines Market Research Report 2026
1 Industry Overview of Artificial Heart Lung Machines
1.1 Definition and Specifications of Artificial Heart Lung Machines
1.1.1 Definition of Artificial Heart Lung Machines
1.1.2 Specifications of Artificial Heart Lung Machines
1.2 Classification of Artificial Heart Lung Machines
1.2.1 Single Roller Pump HLM
1.2.2 Double Roller Pump HLM
1.3 Applications of Artificial Heart Lung Machines
1.3.1 Cardiac Surgery
1.3.2 Lung Transplant Operation
1.3.3 Acute Respiratory Failure Treatment
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines
2.3 Manufacturing Process Analysis of Artificial Heart Lung Machines
2.4 Industry Chain Structure of Artificial Heart Lung Machines
3 Technical Data and Manufacturing Plants Analysis of Artificial Heart Lung Machines
3.1 Capacity and Commercial Production Date of Global Artificial Heart Lung Machines Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Artificial Heart Lung Machines Major Manufacturers
3.3 R&D Status and Technology Source of Global Artificial Heart Lung Machines Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Artificial Heart Lung Machines Major Manufacturers
4 Global Artificial Heart Lung Machines Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Artificial Heart Lung Machines Capacity and Growth Rate Analysis
4.2.2 Artificial Heart Lung Machines Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Artificial Heart Lung Machines Sales and Growth Rate Analysis
4.3.2 Artificial Heart Lung Machines Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Artificial Heart Lung Machines Sales Price
4.4.2 Artificial Heart Lung Machines Sales Price Analysis (Company Segment)
5 Artificial Heart Lung Machines Regional Market Analysis
5.1 North America Artificial Heart Lung Machines Market Analysis
5.1.1 North America Artificial Heart Lung Machines Market Overview
5.1.2 North America E Artificial Heart Lung Machines Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Artificial Heart Lung Machines Sales Price Analysis
5.1.4 North America Artificial Heart Lung Machines Market Share Analysis
5.2 Europe Artificial Heart Lung Machines Market Analysis
5.2.1 Europe Artificial Heart Lung Machines Market Overview
5.2.2 Europe E Artificial Heart Lung Machines Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Artificial Heart Lung Machines Sales Price Analysis
5.2.4 Europe Artificial Heart Lung Machines Market Share Analysis
5.3 China Artificial Heart Lung Machines Market Analysis
5.3.1 China Artificial Heart Lung Machines Market Overview
5.3.2 China E Artificial Heart Lung Machines Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Artificial Heart Lung Machines Sales Price Analysis
5.3.4 China Artificial Heart Lung Machines Market Share Analysis
5.4 Japan Artificial Heart Lung Machines Market Analysis
5.4.1 Japan Artificial Heart Lung Machines Market Overview
5.4.2 Japan E Artificial Heart Lung Machines Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Artificial Heart Lung Machines Sales Price Analysis
5.4.4 Japan Artificial Heart Lung Machines Market Share Analysis
5.5 Southeast Asia Artificial Heart Lung Machines Market Analysis
5.5.1 Southeast Asia Artificial Heart Lung Machines Market Overview
5.5.2 Southeast Asia E Artificial Heart Lung Machines Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Artificial Heart Lung Machines Sales Price Analysis
5.5.4 Southeast Asia Artificial Heart Lung Machines Market Share Analysis
5.6 India Artificial Heart Lung Machines Market Analysis
5.6.1 India Artificial Heart Lung Machines Market Overview
5.6.2 India E Artificial Heart Lung Machines Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Artificial Heart Lung Machines Sales Price Analysis
5.6.4 India Artificial Heart Lung Machines Market Share Analysis
6 Global E Artificial Heart Lung Machines Segment Market Analysis (by Type)
6.1 Global E Artificial Heart Lung Machines Sales by Type
6.2 Different Types of Artificial Heart Lung Machines Product Interview Price Analysis
6.3 Different Types of Artificial Heart Lung Machines Product Driving Factors Analysis
6.3.1 Single Roller Pump HLM Growth Driving Factor Analysis
6.3.2 Double Roller Pump HLM Growth Driving Factor Analysis
7 Global E Artificial Heart Lung Machines Segment Market Analysis (by Application)
7.1 Global E Artificial Heart Lung Machines Consumption by Application
7.2 Different Application of Artificial Heart Lung Machines Product Interview Price Analysis
7.3 Different Application of Artificial Heart Lung Machines Product Driving Factors Analysis
7.3.1 Cardiac Surgery of Artificial Heart Lung Machines Growth Driving Factor Analysis
7.3.2 Lung Transplant Operation of Artificial Heart Lung Machines Growth Driving Factor Analysis
7.3.3 Acute Respiratory Failure Treatment of Artificial Heart Lung Machines Growth Driving Factor Analysis
7.3.4 Others of Artificial Heart Lung Machines Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Artificial Heart Lung Machines
8.1 LivaNova (Sorin)
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Business Region Distribution Analysis
8.2 Getinge (Maquet)
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Getinge (Maquet) Artificial Heart Lung Machines Business Region Distribution Analysis
8.3 Medtronic
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Medtronic Artificial Heart Lung Machines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Medtronic Artificial Heart Lung Machines Business Region Distribution Analysis
8.4 Terumo CV Group
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Terumo CV Group Artificial Heart Lung Machines Business Region Distribution Analysis
8.5 Braile Biomedica
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Braile Biomedica Artificial Heart Lung Machines Business Region Distribution Analysis
8.6 Tianjin Medical
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Tianjin Medical Artificial Heart Lung Machines Business Region Distribution Analysis
9 Development Trend of Analysis of Artificial Heart Lung Machines Market
9.1 Global Artificial Heart Lung Machines Market Trend Analysis
9.1.1 Global 2018-2025 Artificial Heart Lung Machines Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Artificial Heart Lung Machines Sales Price Forecast
9.2 Artificial Heart Lung Machines Regional Market Trend
9.2.1 North America 2018-2025 Artificial Heart Lung Machines Consumption Forecast
9.2.2 Europe 2018-2025 Artificial Heart Lung Machines Consumption Forecast
9.2.3 China 2018-2025 Artificial Heart Lung Machines Consumption Forecast
9.2.4 Japan 2018-2025 Artificial Heart Lung Machines Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Artificial Heart Lung Machines Consumption Forecast
9.2.6 India 2018-2025 Artificial Heart Lung Machines Consumption Forecast
9.3 Artificial Heart Lung Machines Market Trend (Product Type)
9.4 Artificial Heart Lung Machines Market Trend (Application)
10 Artificial Heart Lung Machines Marketing Type Analysis
10.1 Artificial Heart Lung Machines Regional Marketing Type Analysis
10.2 Artificial Heart Lung Machines International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Artificial Heart Lung Machines by Region
10.4 Artificial Heart Lung Machines Supply Chain Analysis
11 Consumers Analysis of Artificial Heart Lung Machines
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Artificial Heart Lung Machines Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Artificial Heart Lung Machines
Table Product Specifications of Artificial Heart Lung Machines
Table Classification of Artificial Heart Lung Machines
Figure Global Production Market Share of Artificial Heart Lung Machines by Type in
Figure Single Roller Pump HLM Picture
Table Major Manufacturers of Single Roller Pump HLM
Figure Double Roller Pump HLM Picture
Table Major Manufacturers of Double Roller Pump HLM
Table Applications of Artificial Heart Lung Machines
Figure Global Consumption Volume Market Share of Artificial Heart Lung Machines by Application in
Figure Cardiac Surgery Examples
Table Major Consumers in Cardiac Surgery
Figure Lung Transplant Operation Examples
Table Major Consumers in Lung Transplant Operation
Figure Acute Respiratory Failure Treatment Examples
Table Major Consumers in Acute Respiratory Failure Treatment
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Artificial Heart Lung Machines by Regions
Figure North America Artificial Heart Lung Machines Market Size (Million USD) (2013-2025)
Figure Europe Artificial Heart Lung Machines Market Size (Million USD) (2013-2025)
Figure China Artificial Heart Lung Machines Market Size (Million USD) (2013-2025)
Figure Japan Artificial Heart Lung Machines Market Size (Million USD) (2013-2025)
Figure Southeast Asia Artificial Heart Lung Machines Market Size (Million USD) (2013-2025)
Figure India Artificial Heart Lung Machines Market Size (Million USD) (2013-2025)
Table Artificial Heart Lung Machines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines in
Figure Manufacturing Process Analysis of Artificial Heart Lung Machines
Figure Industry Chain Structure of Artificial Heart Lung Machines
Table Capacity and Commercial Production Date of Global Artificial Heart Lung Machines Major Manufacturers
Table Manufacturing Plants Distribution of Global Artificial Heart Lung Machines Major Manufacturers
Table R&D Status and Technology Source of Global Artificial Heart Lung Machines Major Manufacturers
Table Raw Materials Sources Analysis of Global Artificial Heart Lung Machines Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Artificial Heart Lung Machines E
Figure Global E Artificial Heart Lung Machines Market Size (Volume) and Growth Rate
Figure Global E Artificial Heart Lung Machines Market Size (Value) and Growth Rate
Table E Global Artificial Heart Lung Machines Capacity and Growth Rate
Table Global Artificial Heart Lung Machines Capacity (Units) List (Company Segment)
Table E Global Artificial Heart Lung Machines Sales (Units) and Growth Rate
Table Global Artificial Heart Lung Machines Sales (Units) List (Company Segment)
Table E Global Artificial Heart Lung Machines Sales Price (K USD/Unit)
Table Global Artificial Heart Lung Machines Sales Price (K USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (Units) of Artificial Heart Lung Machines E
Figure North America E Artificial Heart Lung Machines Sales Price (K USD/Unit)
Figure North America Artificial Heart Lung Machines Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (Units) of Artificial Heart Lung Machines E
Figure Europe E Artificial Heart Lung Machines Sales Price (K USD/Unit)
Figure Europe Artificial Heart Lung Machines Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (Units) of Artificial Heart Lung Machines E
Figure China E Artificial Heart Lung Machines Sales Price (K USD/Unit)
Figure China Artificial Heart Lung Machines Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (Units) of Artificial Heart Lung Machines E
Figure Japan E Artificial Heart Lung Machines Sales Price (K USD/Unit)
Figure Japan Artificial Heart Lung Machines Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (Units) of Artificial Heart Lung Machines E
Figure Southeast Asia E Artificial Heart Lung Machines Sales Price (K USD/Unit)
Figure Southeast Asia Artificial Heart Lung Machines Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (Units) of Artificial Heart Lung Machines E
Figure India E Artificial Heart Lung Machines Sales Price (K USD/Unit)
Figure India Artificial Heart Lung Machines Sales Market Share
Table Global E Artificial Heart Lung Machines Sales (Units) by Type
Table Different Types Artificial Heart Lung Machines Product Interview Price
Table Global E Artificial Heart Lung Machines Sales (Units) by Application
Table Different Application Artificial Heart Lung Machines Product Interview Price
Table LivaNova (Sorin) Information List
Table Product Overview
Table LivaNova (Sorin) Artificial Heart Lung Machines Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure LivaNova (Sorin) Artificial Heart Lung Machines Business Region Distribution
Table Getinge (Maquet) Information List
Table Product Overview
Table Getinge (Maquet) Artificial Heart Lung Machines Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure Getinge (Maquet) Artificial Heart Lung Machines Business Region Distribution
Table Medtronic Information List
Table Product Overview
Table Medtronic Artificial Heart Lung Machines Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure Medtronic Artificial Heart Lung Machines Business Region Distribution
Table Terumo CV Group Information List
Table Product Overview
Table Terumo CV Group Artificial Heart Lung Machines Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure Terumo CV Group Artificial Heart Lung Machines Business Region Distribution
Table Braile Biomedica Information List
Table Product Overview
Table Braile Biomedica Artificial Heart Lung Machines Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure Braile Biomedica Artificial Heart Lung Machines Business Region Distribution
Table Tianjin Medical Information List
Table Product Overview
Table Tianjin Medical Artificial Heart Lung Machines Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure Tianjin Medical Artificial Heart Lung Machines Business Region Distribution
Figure Global 2018-2025 Artificial Heart Lung Machines Market Size (Units) and Growth Rate Forecast
Figure Global 2018-2025 Artificial Heart Lung Machines Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Artificial Heart Lung Machines Sales Price (K USD/Unit) Forecast
Figure North America 2018-2025 Artificial Heart Lung Machines Consumption Volume (Units) and Growth Rate Forecast
Figure China 2018-2025 Artificial Heart Lung Machines Consumption Volume (Units) and Growth Rate Forecast
Figure Europe 2018-2025 Artificial Heart Lung Machines Consumption Volume (Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Artificial Heart Lung Machines Consumption Volume (Units) and Growth Rate Forecast
Figure Japan 2018-2025 Artificial Heart Lung Machines Consumption Volume (Units) and Growth Rate Forecast
Figure India 2018-2025 Artificial Heart Lung Machines Consumption Volume (Units) and Growth Rate Forecast
Table Global Sales Volume (Units) of Artificial Heart Lung Machines by Type 2018-2025
Table Global Consumption Volume (Units) of Artificial Heart Lung Machines by Application 2018-2025
Table Traders or Distributors with Contact Information of Artificial Heart Lung Machines by Region
Segments Analysis
-
By Product Type & Configuration:
-
Integrated Console-Based Systems: The conventional, dominant segment featuring a single console integrating the blood pump, oxygenator, heat exchanger, venous reservoir, and sophisticated monitoring/safety systems. Engineered for the highest level of control and safety in major cardiac centers.
-
Modular & Mobile Systems: Flexible configurations that allow for greater customization and adaptability. Often used in hybrid operating rooms, trauma centers, or for specialized procedures like minimally invasive cardiac surgery (MICS) and thoracic aortic repairs.
-
Disposables & Consumables (High-Volume Segment): Includes oxygenators, centrifugal pumps, tubing packs, cannulae, and filters. This is a high-growth, recurring revenue segment driven by procedure volumes and stringent single-use protocols to prevent infection.
-
-
By Pump Technology:
-
Centrifugal Pumps: The modern standard, generating flow through constrained vortex or impeller designs. They are associated with reduced hemolysis, lower risk of air embolism, and afterload sensitivity, enhancing patient safety.
-
Roller Pumps: Traditional positive displacement pumps still in use in some settings for specific applications like pediatric surgery or cardioplegia delivery, but largely superseded by centrifugal technology for main arterial support.
-
-
By Application:
-
Cardiac Surgery: The primary application, including Coronary Artery Bypass Grafting (CABG), Valve Repair/Replacement, and Congenital Heart Defect Corrections.
-
Extracorporeal Membrane Oxygenation (ECMO): A rapidly growing application where portable heart-lung machines provide temporary cardiac and/or respiratory support for critically ill patients (e.g., severe ARDS, post-cardiotomy shock, bridge to transplant).
-
Other: Includes use in lung transplant surgeries and major thoracic aortic procedures.
-
Regional Analysis
-
North America: The largest market, driven by high procedure volumes, advanced healthcare infrastructure, favorable reimbursement frameworks, and early adoption of next-generation perfusion technologies and minimally invasive surgical techniques.
-
Europe: A mature market with high standards for patient safety and quality. Growth is supported by an aging population, high incidence of CVD, and strong clinical research in perfusion science and ECMO.
-
Asia-Pacific: The fastest-growing regional market. Explosive growth is fueled by rising healthcare expenditures, expanding access to cardiac care, increasing medical tourism, growing surgical volumes in China, India, Japan, and South Korea, and significant investments in hospital infrastructure.
-
Latin America, Middle East & Africa: Emerging markets with gradual growth potential. Growth is concentrated in major urban medical centers and is driven by government initiatives to modernize cardiac care and the training of specialized cardiac surgical teams.
Competitive Landscape & Key Players
The market is consolidated, dominated by a few global medical technology giants with extensive portfolios in cardiac surgery.
-
Global Market Leaders: Getinge AB (Maquet), LivaNova PLC, Medtronic plc, Terumo Cardiovascular Systems Corporation.
-
Specialized & Niche Players: Xenios AG (Fresenius Medical Care) (focused on ECMO and advanced life support), Eurosets S.r.l., Chalice Medical Ltd., Nipro Medical Corporation.
-
Disposables & Consumables Manufacturers: In addition to the above, companies like Microport Scientific Corporation, Braile Biomédica, and several regional manufacturers compete in the high-volume consumables segment.
